¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼ö±âº°, ½Ã¼úº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End Use, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1726176
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 125 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,526,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,250 £Ü 5,919,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,705,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå µ¿Çâ

¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 9¾ï 9,840¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025-2030³â¿¡ °ÉÃÄ CAGR 8.17%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ¾Ï ÀÌȯÀ² Áõ°¡, Àúħ½À ¼ö¼úÀÇ ±â¼úÀû Áøº¸ Áõ°¡, ÁßÀçÀû Á¾¾çÇÐ ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÀÌ ³ª¶ó¿¡¼­ÀÇ ³ëÀÎ Áõ°¡¿¡ ÀÇÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹¿¡¼­ ¾Ï À¯º´·üÀÇ »ó½ÂÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¼± ¿ä¹ý°ú °°Àº ÀüÅëÀûÀÎ Ä¡·á´Â Á¾Á¾ ½É°¢ÇÑ ºÎÀÛ¿ëÀ» µ¿¹ÝÇϱ⠶§¹®¿¡ °íÁÖÆÄ ¼ÒÀÛ¼ú°ú ¸¶ÀÌÅ©·ÎÆÄ ¼ÒÀÛ¼ú°ú °°Àº Àúħ½À ´ëü ¿ä¹ýÀÌ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù.

ÁßÀçÀû Á¾¾çÇÐÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸´Â ÀÌ·¯ÇÑ ÀýÂ÷ÀÇ È¿°ú¿Í äÅÃÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡ ÁøÀÔÇÑ ±â¾÷Àº ¼±ÁøÀûÀÎ Á¦Ç°À» ½ÃÀå¿¡ ÅõÀÔÇϱâ À§ÇÑ ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇÏ¿© ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Profound MedicalÀº 2023³â 9¿ù, Àü¸³¼±ÀÇ Æ¯Á¤ ºÎÀ§ÀÇ ÀýÁ¦ ¿Âµµ¸¦ ÀϽÃÀûÀ¸·Î »ó½Â½ÃŰ´Â TULSA-PRO Thermal Boost ¸ðµâ¿¡ ´ëÇØ ¹Ì±¹ FDA·ÎºÎÅÍ 510(k) Àΰ¡¸¦ ÃëµæÇß½À´Ï´Ù. ÀÌ Thermal Boost ±â´ÉÀº Àü¸³¼± ¾Ï »ç·ÊÀÇ 88%¿¡¼­ Ä¡·á ¼ºÀûÀÌ Çâ»óµÇ¾úÀ¸¸ç, Ä¡·á È¿°ú¿Í ¿öÅ©Ç÷οì È¿À² ¸ðµÎ °³¼±µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â ÀÓ»ó °á°ú¸¦ °³¼±Çϰí ÀÇ·á Á¦°ø¾÷üµé »çÀÌ¿¡¼­ ÁßÀçÀû Á¾¾çÇÐÀÇ ¸Å·ÂÀ» ³ôÀÔ´Ï´Ù.

¹Ì±¹¿¡¼­´Â ¹Î°£ÀÎ ¸ðµÎÀÇ ÁßÀçÀû Á¾¾çÇп¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ°í ÀÖÀ¸¸ç ½ÃÀå È®´ë°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. °³¹ß, ¿¬±¸°³¹ß, º¥Ã³Ä³ÇÇÅ»·ÎºÎÅÍÀÇ ÅõÀÚ´Â °íÁ¤¹Ð Á¾¾çÇÐÀ» Çâ»ó½ÃŰ´Â Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÇ °³¹ßÀ» Áö¿øÇϰí ÀÖÀ¸¸ç, ÀÎÅͺ¥¼Å³Î ±â¼úÀÌ ÁÖ·ùÀÇ ¾Ï Ä¡·á¿¡ ÅëÇյǴ °ÍÀ» È®½ÇÈ÷ Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 12¿ù, ÀÎÅͺ¥¼Å³Î ¶óµð¿Ã·ÎÁö ÇÐȸ(SIR) Àç´ÜÀº 4°³ÀÇ ¿¬±¸ ÇÁ·ÎÁ§Æ®¿¡ 150¸¸ ´Þ·¯ÀÇ º¸Á¶±ÝÀ» ¼ö¿©Çß½À´Ï´Ù. Çϳª´Â °£¼¼Æ÷¾Ï(HCC)ÀÇ »õ·Î¿î ¸ðµ¨À» °³¹ßÇÏ´Â ¿¬±¸À̰í, ´Ù¸¥ Çϳª´Â HCC¿¡ ´ëÇÑ Á¤¹Ð À¯µµ ÀÎÅͺ¥¼Å³ÎÀ» À§ÇØ À¯ÀüÀÚ ¼­ºêŸÀÌÇÎÀ» ÀÌ¿ëÇÏ´Â ¿¬±¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå : ¼ö±âº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦5Àå ¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå : ½Ã¼úº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦6Àå ¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ Àç·á ½ÃÀå : ¿ëµµº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦7Àå ¹Ì±¹ÀÇ ÁßÀçÀû Á¾¾çÇÐ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦8Àå °æÀï ±¸µµ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Interventional Oncology Market Trends:

The U.S. interventional oncology market size was estimated at USD 998.4 million in 2024 and is projected to grow at a CAGR of 8.17% from 2025 to 2030. The market is growing due to increasing cancer prevalence, rising technological advancements in minimally invasive procedures, increasing investments in the field of interventional oncology, and the growing geriatric population in the country.

The rising prevalence of cancer in the U.S. is a major factor driving the market growth. According to the American Cancer Society, around. 2,041,910 new cancers are estimated to occur in the U.S. in 2025, while cancer is expected to cause 618,120 mortalities in the same year. As traditional treatments such as chemotherapy and radiation therapy often have significant side effects, minimally invasive alternatives such as radiofrequency ablation and microwave ablation are gaining popularity. These procedures offer localized tumor destruction with minimal damage to surrounding tissues, improving patient outcomes and driving demand for interventional oncology solutions.

Continuous technological advancements in interventional oncology are enhancing the effectiveness and adoption of these procedures. Companies operating in the market are focusing on innovation to introduce advanced products in the market, thereby improving patient outcomes. For instance, in September 2023, Profound Medical obtained 510(k) clearance from the U.S. FDA for its TULSA-PRO Thermal Boost module, which allows surgeons to temporarily elevate ablation temperatures in specific areas of the prostate. The Thermal Boost feature has led to improved treatment results in 88% of prostate cancer cases, thereby enhancing both efficacy and workflow efficiency. Such advancements improve clinical outcomes and increase the appeal of interventional oncology among healthcare providers.

The growing investment in interventional oncology from both public and private sectors is accelerating market expansion in the U.S. Government initiatives, research funding, and venture capital investments are supporting the development of innovative treatment modalities to improve precision oncology, ensuring that interventional techniques are integrated into mainstream cancer care. For instance, in December 2024, the Society of Interventional Radiology (SIR) Foundation awarded USD 1.5 million in grants to four research projects, two of which focus on interventional oncology. One study will develop a novel model of hepatocellular carcinoma (HCC), and the other will use genetic subtyping for precision-guided interventions for HCC.

U.S. Interventional Oncology Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. interventional oncology market report based on techniques, procedures, application, end use:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Interventional Oncology Market Variables, Trends & Scope

Chapter 4. U.S. Interventional Oncology Market: Technique Estimates & Trend Analysis

Chapter 5. U.S. Interventional Oncology Market: Procedures Estimates & Trend Analysis

Chapter 6. U.S. Interventional Oncology Materials Market: Applications Estimates & Trend Analysis

Chapter 7. U.S. Interventional Oncology Market: End-use Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â